A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.

NCT07283367 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

502

Enrollment

INDUSTRY

Sponsor class

Conditions

CRC

Interventions

DRUG: Cohort 1: HS-20110+ Bevacizumab+5-FU/leucovorin
DRUG: Cohort 2: HS-20110+Bevacizumab+Oxaliplatin+5-FU/leucovorin
DRUG: Cohort 3: HS-20110+Bevacizumab+Oxaliplatin+Capecitabine

Sponsor

Hansoh BioMedical R&D Company